Abstract

Purpose: Osteoarthritis (OA) is a degenerative joint disease characterized by inflammation and irreversible cartilage damage. The development of OA is associated with dysregulated transforming growth factor-β (TGF-β) signaling, e.g. with loss of SMAD2/3 signaling. Via intracellular activation of these transcription factors TGF-β inhibits chondrocyte hypertrophy and expression of cartilage degrading enzymes. Recently, it has been shown that post-translational modification of these SMAD proteins in their linker protein domain can dysregulate their function.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call